NO20042365L - Kombinasjonsterapi omfattende ZD6474 og et taxan - Google Patents

Kombinasjonsterapi omfattende ZD6474 og et taxan

Info

Publication number: NO20042365L
Authority: NO; Norway
Prior art keywords: taxane; combination therapy; therapy; combination
Prior art date: 2001-11-08

Application number

NO20042365A

Other languages

English (en)

Other versions

NO328048B1 (no

Inventor

Stephen Robert Wedge

Original Assignee

Astrazeneca Ab Global Ip

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-08

Filing date

2004-06-07

Publication date

2004-06-07

2004-06-07 Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip

2004-06-07 Publication of NO20042365L publication Critical patent/NO20042365L/no

2009-11-16 Publication of NO328048B1 publication Critical patent/NO328048B1/no

Links

229940123237 Taxane Drugs 0.000 title 1
238000002648 combination therapy Methods 0.000 title 1
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20042365A 2001-11-08 2004-06-07 Farmasoytisk preparat omfattende ZD6474 og et taxan, sett omfattende samme samt anvendelse av samme for fremstilling av medikament for behandling av sykdom NO328048B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0126879.6A GB0126879D0 (en)	2001-11-08	2001-11-08	Combination therapy
PCT/GB2002/005021 WO2003039551A1 (en)	2001-11-08	2002-11-06	Combination therapy comprising zd6474 and a taxane

Publications (2)

Publication Number	Publication Date
NO20042365L true NO20042365L (no)	2004-06-07
NO328048B1 NO328048B1 (no)	2009-11-16

Family

ID=9925430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042365A NO328048B1 (no)	2001-11-08	2004-06-07	Farmasoytisk preparat omfattende ZD6474 og et taxan, sett omfattende samme samt anvendelse av samme for fremstilling av medikament for behandling av sykdom

Country Status (22)

Country	Link
US (2)	US20050043395A1 (no)
EP (1)	EP1446124B1 (no)
JP (1)	JP4694127B2 (no)
KR (1)	KR100959607B1 (no)
CN (1)	CN1298328C (no)
AR (1)	AR037346A1 (no)
AT (1)	ATE335488T1 (no)
AU (1)	AU2002337382B2 (no)
BR (1)	BR0213906A (no)
CA (1)	CA2464758C (no)
CY (1)	CY1106259T1 (no)
DE (1)	DE60213845T2 (no)
DK (1)	DK1446124T3 (no)
ES (1)	ES2269769T3 (no)
GB (1)	GB0126879D0 (no)
IL (2)	IL161744A0 (no)
MX (1)	MXPA04004355A (no)
NO (1)	NO328048B1 (no)
NZ (1)	NZ532525A (no)
PT (1)	PT1446124E (no)
WO (1)	WO2003039551A1 (no)
ZA (1)	ZA200403455B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100376567C (zh)	1999-11-05	2008-03-26	阿斯特拉曾尼卡有限公司	作为vegf抑制剂的喹唑啉衍生物
GB0008269D0 (en) *	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
US7160889B2 (en) *	2000-04-07	2007-01-09	Astrazeneca Ab	Quinazoline compounds
CN1625555A (zh)	2002-02-01	2005-06-08	阿斯特拉曾尼卡有限公司	喹唑啉化合物
TWI324597B (en) *	2002-03-28	2010-05-11	Astrazeneca Ab	Quinazoline derivatives
GB0218526D0 (en) *	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en) *	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
US7462623B2 (en)	2002-11-04	2008-12-09	Astrazeneca Ab	Quinazoline derivatives as Src tyrosine kinase inhibitors
DK1592423T3 (da) *	2003-02-13	2011-06-27	Astrazeneca Ab	Kombinationsterapi af ZD6474 med 5-FU og/eller CPT-11
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
US20060167027A1 (en) *	2003-07-10	2006-07-27	Wedge Stephen R	Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
CN1897949A (zh) *	2003-11-14	2007-01-17	马尔药品公司	包含使用et－743和紫杉醇来治疗癌症的联合疗法
GB0406445D0 (en) *	2004-03-23	2004-04-28	Astrazeneca Ab	Combination therapy
GB0411378D0 (en) *	2004-05-21	2004-06-23	Astrazeneca Ab	Pharmaceutical compositions
CA2571421A1 (en) *	2004-06-24	2006-01-05	Nicholas Valiante	Compounds for immunopotentiation
MX2007003505A (es) *	2004-09-27	2007-05-10	Astrazeneca Ab	Combinacion que comprende zd6474 e imatinib.
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
GB0519879D0 (en)	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
DE602006020621D1 (de) *	2005-12-22	2011-04-21	Astrazeneca Ab	Kombination von zd6474 und pemetrexed
EP2338488A1 (en) *	2006-05-26	2011-06-29	Bayer HealthCare, LLC	Drug combinations with substituted diaryl ureas for the treatment of cancer
WO2008037996A1 (en) *	2006-09-29	2008-04-03	Astrazeneca Ab	Combination of zd6474 and bevacizumab for cancer therapy
US20080190689A1 (en) *	2007-02-12	2008-08-14	Ballard Ebbin C	Inserts for engine exhaust systems
NZ589883A (en)	2008-05-13	2012-06-29	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy} quinazoline
WO2010061208A2 (en) *	2008-11-03	2010-06-03	Astrazeneca Ab	Therapeutic treatment 555
CN106478598B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种凡德他尼水合物晶体及其制备方法
CN106397401B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种抗癌药物的晶体化合物及其制备方法
CA3202057A1 (en) *	2020-12-22	2022-06-30	Jae Yul Choi	Novel quinazoline derivative compound as sos1 inhibitor, and use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5565478A (en) *	1994-03-14	1996-10-15	The United States Of America As Represented By The Department Of Health & Human Services	Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
CA2252584C (en) *	1996-04-26	2008-06-10	Magainin Pharmaceuticals Inc.	Treatment of carcinomas using squalamine in combination with other anti-cancer agents
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
GB9727524D0 (en) *	1997-12-31	1998-02-25	Pharmacia & Upjohn Spa	Synergistic antitumor composition containing a biologically active ureido compound
AU768027B2 (en) *	1999-02-24	2003-11-27	Uab Research Foundation, The	Taxane derivatives for targeted therapy of cancer
IL145941A (en) *	1999-04-28	2007-08-19	Univ Texas	Compositions and methods for cancer treatment by selectively inhibiting vegf
CN100376567C (zh) *	1999-11-05	2008-03-26	阿斯特拉曾尼卡有限公司	作为vegf抑制剂的喹唑啉衍生物
TWI310684B (en) *	2000-03-27	2009-06-11	Bristol Myers Squibb Co	Synergistic pharmaceutical kits for treating cancer
GB0008269D0 (en) *	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
US20050222183A1 (en) *	2002-08-09	2005-10-06	Wedge Stephen R	Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
GB0218526D0 (en) *	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
GB0223380D0 (en) *	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
DK1592423T3 (da) *	2003-02-13	2011-06-27	Astrazeneca Ab	Kombinationsterapi af ZD6474 med 5-FU og/eller CPT-11
US20060167027A1 (en) *	2003-07-10	2006-07-27	Wedge Stephen R	Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
MX2007003505A (es) *	2004-09-27	2007-05-10	Astrazeneca Ab	Combinacion que comprende zd6474 e imatinib.
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
DE602006020621D1 (de) *	2005-12-22	2011-04-21	Astrazeneca Ab	Kombination von zd6474 und pemetrexed
WO2008037996A1 (en) *	2006-09-29	2008-04-03	Astrazeneca Ab	Combination of zd6474 and bevacizumab for cancer therapy

2001
- 2001-11-08 GB GBGB0126879.6A patent/GB0126879D0/en not_active Ceased
2002
- 2002-11-06 DK DK02772624T patent/DK1446124T3/da active
- 2002-11-06 MX MXPA04004355A patent/MXPA04004355A/es active IP Right Grant
- 2002-11-06 PT PT02772624T patent/PT1446124E/pt unknown
- 2002-11-06 CN CNB028267958A patent/CN1298328C/zh not_active Expired - Fee Related
- 2002-11-06 IL IL16174402A patent/IL161744A0/xx unknown
- 2002-11-06 AT AT02772624T patent/ATE335488T1/de active
- 2002-11-06 US US10/494,704 patent/US20050043395A1/en not_active Abandoned
- 2002-11-06 KR KR1020047007020A patent/KR100959607B1/ko not_active Expired - Fee Related
- 2002-11-06 NZ NZ532525A patent/NZ532525A/en not_active IP Right Cessation
- 2002-11-06 CA CA2464758A patent/CA2464758C/en not_active Expired - Fee Related
- 2002-11-06 ES ES02772624T patent/ES2269769T3/es not_active Expired - Lifetime
- 2002-11-06 EP EP02772624A patent/EP1446124B1/en not_active Expired - Lifetime
- 2002-11-06 JP JP2003541842A patent/JP4694127B2/ja not_active Expired - Fee Related
- 2002-11-06 WO PCT/GB2002/005021 patent/WO2003039551A1/en not_active Ceased
- 2002-11-06 BR BR0213906-5A patent/BR0213906A/pt not_active IP Right Cessation
- 2002-11-06 AU AU2002337382A patent/AU2002337382B2/en not_active Ceased
- 2002-11-06 DE DE60213845T patent/DE60213845T2/de not_active Expired - Lifetime
- 2002-11-08 AR ARP020104292A patent/AR037346A1/es not_active Application Discontinuation
2004
- 2004-05-03 IL IL161744A patent/IL161744A/en not_active IP Right Cessation
- 2004-05-06 ZA ZA200403455A patent/ZA200403455B/en unknown
- 2004-06-07 NO NO20042365A patent/NO328048B1/no not_active IP Right Cessation
2006
- 2006-11-09 CY CY20061101619T patent/CY1106259T1/el unknown
2011
- 2011-11-07 US US13/290,730 patent/US20120252827A1/en not_active Abandoned

Also Published As

Publication number	Publication date
IL161744A0 (en)	2005-11-20
CA2464758A1 (en)	2003-05-15
ATE335488T1 (de)	2006-09-15
MXPA04004355A (es)	2004-08-11
KR20050043779A (ko)	2005-05-11
PT1446124E (pt)	2006-12-29
DK1446124T3 (da)	2006-11-13
IL161744A (en)	2012-01-31
GB0126879D0 (en)	2002-01-02
CA2464758C (en)	2010-09-28
BR0213906A (pt)	2004-08-31
US20050043395A1 (en)	2005-02-24
EP1446124B1 (en)	2006-08-09
CN1298328C (zh)	2007-02-07
AR037346A1 (es)	2004-11-03
NZ532525A (en)	2006-11-30
CN1612738A (zh)	2005-05-04
JP2005511597A (ja)	2005-04-28
NO328048B1 (no)	2009-11-16
AU2002337382B2 (en)	2008-06-12
DE60213845T2 (de)	2007-03-29
JP4694127B2 (ja)	2011-06-08
ZA200403455B (en)	2005-08-29
ES2269769T3 (es)	2007-04-01
CY1106259T1 (el)	2011-06-08
KR100959607B1 (ko)	2010-05-27
WO2003039551A1 (en)	2003-05-15
HK1068546A1 (en)	2005-04-29
US20120252827A1 (en)	2012-10-04
EP1446124A1 (en)	2004-08-18
DE60213845D1 (de)	2006-09-21

Legal Events

Date	Code	Title	Description
2014-06-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
DK1446124T3 (da)	2006-11-13	Kombinationsterapi, der omfatter ZD6474 og et taxan
DK1513873T3 (da)	2014-11-03	Terapeutiske epitoper og anvendelser deraf
EP1453581A4 (en)	2007-07-11	Object recognition toys and games
EP1412378A4 (en)	2006-09-20	APTAMERS AND ANTIAPTAMERS
GB2421695B (en)	2006-11-08	Gaming environment including portable transaction devices
DK1370128T3 (da)	2014-05-26	Kombineret ballepresse og ballevikler
DK1519770T3 (da)	2013-09-30	Elektroporesisk indretning og indsprøjtningsapparat
DE60144138D1 (de)	2011-04-14	Lichtemittierende Vorrichtungen und lichtemittierende Anzeigevorrichtungen
NO20035559L (no)	2004-02-16	Personlig spilleanordning
DE60230583D1 (de)	2009-02-12	Spielvorrichtung und Spielprogramm
FR2823558B1 (fr)	2005-10-21	Glaciere portable
PT1558595E (pt)	2010-01-15	Piperazinil e diazepanil benzamidas e benzotioamidas
GB0203933D0 (en)	2002-04-03	Portable dummy sterilizer
NO20034022L (no)	2003-09-11	En kombinasjon omfattende combretastatin og anticancermidler
GB0111505D0 (en)	2001-07-04	A portable sauna
AU148766S (en)	2002-08-05	Portable drill
DK1456377T3 (da)	2019-09-23	Syn3-sammensætninger og fremgangsmåder
NO20033709L (no)	2003-10-22	Medisinske preparater omfattende Diklofenak og Ornoprostil
NO20032821D0 (no)	2003-06-19	Sea-trosy og beslektede fremgangsmåter
SI1446124T1 (sl)	2006-12-31	Kombinacijska terapija, ki obsega ZD6474 in taksan
DE60219418D1 (de)	2007-05-24	Silanylphenole und -naphthole
TW570251U (en)	2004-01-01	Portable exercise and worship counter device
GB2380689B (en)	2004-12-29	Portable step
PL112305U1 (en)	2002-12-30	Portable game
GB0100515D0 (en)	2001-02-21	Music teaching game